共 50 条
- [1] PCA3 PREDICTS PROSTATE BIOPSY OUTCOME IN MEN RECEIVING DUTASTERIDE: RESULTS FROM THE DUTASTERIDE REDUCE TRIALEUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 306 - 306Andriole, G.Aubin, S. M. J.Reid, J.Samo, M. J.Blase, A.Aussie, J.Rittenhouse, H.Roger, R.Groskopf, J.
- [2] Prostate Cancer Gene 3 Score Predicts Prostate Biopsy Outcome in Men Receiving Dutasteride for Prevention of Prostate Cancer: Results From the REDUCE TrialUROLOGY, 2011, 78 (02) : 380 - 385Aubin, Sheila M. J.Reid, JenniferSarno, Mark J.Blase, AmyAussie, JacquelineRittenhouse, HarryRittmaster, Roger S.Andriole, Gerald L.Groskopf, Jack
- [3] VALIDATION OF THE PCA3 MOLECULAR URINE TEST FOR PREDICTING REPEAT PROSTATE BIOPSY OUTCOME IN THE PLACEBO ARM OF THE DUTASTERIDE REDUCE TRIALJOURNAL OF UROLOGY, 2010, 183 (04): : E823 - E823Marks, LeonardAubin, SheilaReid, JenniferSarno, MarkBlase, AmyAussie, JacquelineRittenhouse, HarryAndriole, GeraldRittmaster, RogerGroskopf, Jack
- [4] VALIDATION OF THE PCA3 MOLECULAR URINE TEST FOR PREDICTING REPEAT PROSTATE BIOPSY OUTCOME IN THE PLACEBO ARM OF THE DUTASTERIDE REDUCE TRIALEUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 306 - 306Rittmaster, R.Aubin, S. M. J.Reid, J.Sarno, M. J.Blase, A.Aussie, J.Rittenhouse, H.Andriole, G. L.Groskopf, J.
- [5] PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE TrialJOURNAL OF UROLOGY, 2010, 184 (05): : 1947 - 1952Aubin, Sheila M. J.Reid, JenniferSarno, Mark J.Blase, AmyAussie, JacquelineRittenhouse, HarryRittmaster, RogerAndriole, Gerald L.Groskopf, Jack
- [6] PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE Trial EDITORIAL COMMENTJOURNAL OF UROLOGY, 2010, 184 (05): : 1952 - 1952Vlaeminck-Guillem, Virginie
- [7] THE UTILITY OF PSA FOR DETECTION OF PROSTATE CANCER IN MEN TRLATED WITH DUTASTERIDE RESULTS FROM THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) STUDYJOURNAL OF MENS HEALTH, 2009, 6 (03) : 269 - 269Andriole, G. L.Bostwick, D.Brawley, O.Gomella, L.Marberger, M.Montorsi, F.Pettaway, C.Tammela, T.Teloken, C.Tindall, D.Wilson, T. H.Somerville, M.Fowler, I.Rittmaster, R. S.
- [8] STATINS SLOW PROSTATE GROWTH: RESULTS FROM THE REDUCTION BY DUTASTERIDE OF CANCER EVENTS (REDUCE) TRIALJOURNAL OF UROLOGY, 2012, 187 (04): : E505 - E505Muller, RobertoGerber, LeahMoreira, DanielAndriole, GeraldParsons, J. KelloggFleshner, NeilFreedland, Stephen
- [9] Efficacy and Safety of Dutasteride on Prostate Cancer Risk Reduction in Asian Men: The Results from the REDUCE StudyJAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (03) : 417 - 423Akaza, HideyukiKanetake, HiroshiTsukamoto, TaijiMiyanaga, NaotoSakai, HidekiMasumori, NaoyaNakatsu, HiroomiSagiyama, KazuyukiSakamoto, SadaakiEndo, YukihiroYamanouchi, Takayoshi
- [10] Does insulin resistance predict prostate cancer? Results from the Reduction by Dutasteride of Prostate Cancer (REDUCE) TrialCANCER, 2025, 131 (01)Zheng, RenningDaniels, James P.Moreira, Daniel M.Eslamimehr, ShakibaFreedland, Alexis R.Guerrios-Rivera, LourdesFowke, Jay H.Freedland, Stephen J.